Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer

• Main Authors: Desmond Curran (Author), Brandon J. Patterson (Author), Justin Carrico (Author), Ahmed Salem (Author), Elizabeth M. La (Author), Stéphane Lorenc (Author), Katherine A. Hicks (Author), Sara Poston (Author), Christopher F. Carpenter (Author)
• Format: Book
• Published: Taylor & Francis Group, 2023-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Individuals who are immunocompromised (IC) due to therapy or underlying disease are at increased risk of herpes zoster (HZ). This study evaluates the public health impact of recombinant zoster vaccine (RZV) relative to no HZ vaccination for the prevention of HZ among adults aged ≥18 years diagnosed...